These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3207350)

  • 1. [The effect of ranitidine on gastric pH measured by continuous monitoring over 24 hours in healthy subjects. Comparison of 2 methods of administration: 150 mg morning and night, vs 300 mg in a single dose at night].
    Bonfils S; Guedon C; Vallot T; Congard P; Garcia del Risco F; Galmiche JP; Denis P; Pappo M
    Ann Gastroenterol Hepatol (Paris); 1988 Oct; 24(5):221-5. PubMed ID: 3207350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single morning and nightly doses of ranitidine 300 mg: an appraisal of their antisecretory effects by continuous pH monitoring.
    Savarino V; Mela GS; Zentilin P; Sumberaz A; Cutela P; Celle G
    Digestion; 1991; 48(3):141-8. PubMed ID: 1916034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bolus or intravenous infusion of ranitidine: effects on gastric pH and acid secretion. A comparison of relative efficacy and cost.
    Ballesteros MA; Hogan DL; Koss MA; Isenberg JI
    Ann Intern Med; 1990 Mar; 112(5):334-9. PubMed ID: 2306061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of food and ranitidine on saquinavir pharmacokinetics and gastric pH in healthy volunteers.
    Kakuda TN; Falcon RW
    Pharmacotherapy; 2006 Aug; 26(8):1060-8. PubMed ID: 16863482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twenty-four-hour control of gastric acidity by twice-daily doses of placebo, nizatidine 150 mg, nizatidine 300 mg, and ranitidine 300 mg.
    Savarino V; Mela GS; Zentilin P; Cutela P; Mele R; Celle G
    J Clin Pharmacol; 1993 Jan; 33(1):70-4. PubMed ID: 8429117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of the timing of administration of 300 mg ranitidine on 24-hour gastric pH in patients acute duodenal ulcer.
    Cortot A; Guillemot F; Moreau J; Soule JC; Veyrac M; Alberola B; Pappo M
    Aliment Pharmacol Ther; 1992 Aug; 6(4):487-93. PubMed ID: 1420740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ranitidine 150 mg four times a day on 24-hour intragastric acidity and 24-hour plasma gastrin concentration.
    Fraser AG; Sawyerr AM; Hudson M; Smith M; Pounder RE
    Dig Dis Sci; 1994 Jan; 39(1):91-6. PubMed ID: 8281874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of a single oral morning dose of nizatidine and ranitidine on intragastric pH under basal conditions and after pentagastrin stimulation.
    Lazzaroni M; Sangaletti O; Bianchi Porro G
    J Int Med Res; 1992 Nov; 20(6):454-60. PubMed ID: 1286739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twenty-four-hour intragastric pH: tolerance within 5 days of continuous ranitidine administration.
    Lachman L; Howden CW
    Am J Gastroenterol; 2000 Jan; 95(1):57-61. PubMed ID: 10638559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Night-time or morning dosing with H2-receptor antagonists: studies on acid inhibition in normal subjects.
    Patel N; Ward U; Rogers MJ; Primrose JN
    Aliment Pharmacol Ther; 1992 Jun; 6(3):381-7. PubMed ID: 1600054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of low doses of ranitidine on intragastric acidity in healthy men.
    Wyeth JW; Pounder RE; Sercombe JC; Snell CC
    Aliment Pharmacol Ther; 1998 Mar; 12(3):255-61. PubMed ID: 9570260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term ambulatory gastric pH monitoring: validation of a new method and effect of H2-antagonists.
    Fimmel CJ; Etienne A; Cilluffo T; von Ritter C; Gasser T; Rey JP; Caradonna-Moscatelli P; Sabbatini F; Pace F; Bühler HW
    Gastroenterology; 1985 Jun; 88(6):1842-51. PubMed ID: 3996841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording.
    Savarino V; Mela GS; Zentilin P; Scalabrini P; Bonifacino G; Gambaro P; Celle G
    Digestion; 1989; 42(1):1-6. PubMed ID: 2568299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous intragastric pH monitoring: a real progress in the assessment of antisecretory drugs.
    Savarino V
    Ital J Gastroenterol; 1990; 22 Suppl 2():20-3. PubMed ID: 1983412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of two dosing regimens of intravenous ranitidine on gastric pH in critically ill children.
    Osteyee JL; Banner W
    Am J Crit Care; 1994 Jul; 3(4):267-72. PubMed ID: 7920954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single dose ranitidine: influence of the time of administration on gastric acidity in normal subjects and in patients with duodenal ulcer.
    Coppens JP; Warzee P; Schapira M; Fiasse R; Dive C
    Gastroenterol Clin Biol; 1988; 12(6-7):537-41. PubMed ID: 3417080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of gastric acidity with ranitidine or famotidine: early evening dosage is more effective than late evening dosage.
    Bauerfeind P; Cilluffo T; Emde C; Fimmel C; Kohler W; Gasser T; Blum AL
    Digestion; 1987; 37(4):217-22. PubMed ID: 2890546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of famotidine and ranitidine in critically ill children.
    Madani S; Kauffman R; Simpson P; Lehr VT; Lai ML; Sarniak A; Tolia V
    J Clin Pharmacol; 2014 Feb; 54(2):201-5. PubMed ID: 24258773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of three different ranitidine dosage regimens on reducing gastric acidity and volume in ambulatory surgical patients.
    O'Connor TA; Basak J; Parker S
    Pharmacotherapy; 1995; 15(2):170-5. PubMed ID: 7624264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of roxatidine acetate on 24-hour intragastric acidity. Investigations in healthy volunteers and comparison with ranitidine and placebo.
    Merki HS; Witzel L; Kaufmann D; Kempf M; Neumann J; Scheurle E; Röhmel J; Walt RP
    Drugs; 1988; 35 Suppl 3():69-75. PubMed ID: 2905252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.